Evidence map›Paper›PMID 33092114›Full record

ArticleCancers2020

Contribution of miRNAs, tRNAs and tRFs to Aberrant Signaling and Translation Deregulation in Lung Cancer.

Ilias Skeparnias, Dimitrios Anastasakis, Katerina Grafanaki, George Kyriakopoulos, Panagiotis Alexopoulos, Dimitrios Dougenis, Andreas Scorilas, Christos K Kontos, Constantinos Stathopoulos

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The Roles of tRNA-Derived Fragments in Cancer: Updates and Perspectives.International journal of molecular sciences · 2025
    Review
  5. Hypoxia-induced tRF-3Frontiers in pharmacology · 2025
    Article
  6. High Intratumoral i-tRF-GlyBiomedicines · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Ilias SkeparniasDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0003-1188-529X
Dimitrios AnastasakisDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.
Katerina GrafanakiDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-6569-1928
George KyriakopoulosDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.
Panagiotis AlexopoulosDepartment of Cardiothoracic Surgery, School of Medicine and University Hospital of Patras, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-5742-1733
Dimitrios DougenisDepartment of Cardiothoracic Surgery, School of Medicine and University Hospital of Patras, University of Patras, 26504 Patras, Greece.
Andreas ScorilasDepartment of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, 10679 Athens, Greece.ORCID 0000-0003-2427-4949
Christos K KontosDepartment of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, 10679 Athens, Greece.ORCID 0000-0002-9935-8461
Constantinos StathopoulosDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-5699-4118
University of Patras · GRNational and Kapodistrian University of Athens · GR

Funding

ARISTEIA I - General Secretariat of Reasearch and Technology of Greece 46080000INSPIRED - General Secretariat of Reasearch and Technology of Greece 5002550
6 · The paper itself

Abstract

Transcriptomics profiles of miRNAs, tRNAs or tRFs are used as biomarkers, after separate examination of several cancer cell lines, blood samples or biopsies. However, the possible contribution of all three profiles on oncogenic signaling and translation as a net regulatory effect, is under investigation. The present analysis of miRNAs and tRFs from lung cancer biopsies indicated putative targets, which belong to gene networks involved in cell proliferation, transcription and translation regulation. In addition, we observed differential expression of specific tRNAs along with several tRNA-related genes with possible involvement in carcinogenesis. Transfection of lung adenocarcinoma cells with two identified tRFs and subsequent NGS analysis indicated gene targets that mediate signaling and translation regulation. Broader analysis of all major signaling and translation factors in several biopsy specimens revealed a crosstalk between the PI3K/AKT and MAPK pathways and downstream activation of eIF4E and eEF2. Subsequent polysome profile analysis and 48S pre-initiation reconstitution experiments showed increased global translation rates and indicated that aberrant expression patterns of translation initiation factors could contribute to elevated protein synthesis. Overall, our results outline the modulatory effects that possibly correlate the expression of important regulatory non-coding RNAs with aberrant signaling and translation deregulation in lung cancer.

Indexed as

lung cancermiRNAssignalingtranslationtRFstRNAs

Identifiers

PMID33092114
PMCPMC7593945
OpenAlexW3094394178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.